About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
Did You Know?
- The number of people in the United States with Parkinson’s disease is estimated to be as many as 1.5 million. Approximately 60,000 Americans are newly diagnosed each year.
- Parkinson’s disease affects about 50 percent more men than women.
- The average age of onset of the disease is 60, with incidence increasing signi? cantly with age. About 5 percent to 10 percent of people have “early-onset” disease that begins as early as age 50 or even earlier.
- Some early-onset diagnoses are linked to specific gene mutations. Total risk for the disease is between 2 percent and 5 percent if no family members have a known gene mutation. About 15 percent to 25 percent of people with Parkinson’s have a relative with the disease.
- Parkinson’s disease is the 14th leading cause of death in the United States.
Medicines in Development for Parkinson's Disease 2014 Report image
Report
Future of Medicine
Medicines in Development for Parkinson's Disease 2014 Report
Medicines in Development for Parkinson's Disease 2014 Report image